A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GAF / Global Assessment of Functioning

[Related PubMed/MEDLINE]
Total Number of Papers: 1086
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GAF  (>> Co-occurring Abbreviation)
Long Form:   Global Assessment of Functioning
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 A systematic review of psychosocial functioning and quality of life in older people with bipolar disorder. BD
2022 A two-year follow-up study on the first manic episode due to mood-incongruent psychosis. ---
2022 Antipsychotic prescription, assumption and conversion to psychosis: resolving missing clinical links to optimize prevention through precision. AP, CHR, EFA, SIPS
2022 Brief Clinical Assessment Scale for Schizophrenia (BCASS): Development, Validity, and Reliability Study. BCASS, CGI-S, PANSS
2022 Clinical and personal recovery for people with schizophrenia in China: prevalence and predictors. BPRS, RAS
2022 Cognitive behavioural therapy (group) for schizophrenia. CBT, CBTp, CI, MD, PANSS, PSP, RR, SDSS, standard care
2022 Comparing continuous and harmonized measures of depression severity in older adults with bipolar disorder: Relationship to functioning. CES-D, GAGE-BD, HAMD, MADRS, OABD
2022 Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. CGI-SCH, M-ECT, MoCA, PANSS, TRS
2022 Determinants of three-year clinical outcomes in real-world outpatients with bipolar disorder: The multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI). BD, MUSUBI, MUSUBI
10  2022 Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies. PSP
11  2022 Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study. CGI-SS, i.n, MADRS, MDD, PTSD, TRD
12  2022 Electroencephalographic Microstates are Correlated with Global Functioning in Schizophrenia But Not in Bipolar Disorder. BD, EEGs, HAMD, PANSS, SCZ
13  2022 Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms. BBB, CGI, SBDP145, SBDP150, UCHL1
14  2022 Factors influencing the duration of hospitalization of patients with schizophrenia. MSPSS, PANSS
15  2022 Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study. MCCB, PANSS
16  2022 Group treatment for complex dissociative disorders: a randomized clinical trial. CDD
17  2022 Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles. BP, FA, GCC, MDD, RD, SCZ
18  2022 Impact of early use of long-acting injectable antipsychotics on functional outcome in first episode psychosis: a 3-year longitudinal study. EIS, OAP
19  2022 Improved depressive symptoms in patients with refractory Gilles de la Tourette syndrome after deep brain stimulation of posteroventral globus pallidus interna. DBS, GPi, GTS, HAM-A, HAMD, Y-BOCS, YGTSS
20  2022 Increased NLRP3 inflammasome expression in peripheral blood mononuclear cells of patients with schizophrenia: a case-control study. FAST, HC, NLRP3, P2X7R, PBMCs, SANS, SCZ
21  2022 Jumping to conclusions correlates with negative symptoms, poor response inhibition, and impaired functioning in individuals diagnosed with schizophrenia. BPRS, FAB, JTC
22  2022 Long-term comparative effectiveness of deep brain stimulation in severe obsessive-compulsive disorder. BNST, DBS, HDRS, OCD, vALIC-Nacc, Y-BOCS
23  2022 Mentalization-oriented psychodynamic group therapy for patients with personality disorders: a naturalistic prospective cohort study. IIP, PDs, PDT, SCL-90-R
24  2022 Motor abnormalities are associated with poor social and functional outcomes in schizophrenia. PS, SOFAS, UPSA-B
25  2022 Multidisciplinary treatment for functional urological disorders with psychosomatic comorbidity in a tertiary pelvic care center-A retrospective cohort study. HADS
26  2022 Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the "Parma Early Psychosis" program. EIP, FES, NS, PANSS
27  2022 NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data. EHR, MSE, NLP, RWD, RWE, TRE
28  2022 Outcomes associated with proton pump inhibitors and distal radius fractures: A post-hoc comparative analysis. DASH, DRF, PPI, PPI, VAS
29  2022 Personality Pathology Explains Functional Impairment in Patients With Hypochondriasis. PID-5, SCID-II, SHAI
30  2022 Predictors of 4-week antidepressant outcome in patients with first-episode major depressive disorder: An ROC curve analysis. AUC, MCCB, MDD
31  2022 Prevalence of Attention Deficit Hyperactivity Disorder in an Adult Mental Health Service in the Republic of Ireland. ADHD, ASRS, CAADID, MINI, WURS
32  2022 Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia. BMQ, BMQ-S, LARS, SANS
33  2022 Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder. MUSUBI
34  2022 Relationships between global functioning and neuropsychological predictors in subjects at high risk of psychosis or with a recent onset of depression. CHR, GF-S, ROD
35  2022 Resource utilization in mental illness - evaluation of an instrument for measuring direct costs of treatment for patients with severe mental illness (SMI). BMI, CGI, RUMI, SMI, SMIs
36  2022 School Refusal Behavior: Role of Personality Styles, Social Functioning, and Psychiatric Symptoms in a Sample of Adolescent Help-Seekers. GFRS, GFSS, HAM-A, HAM-D, MRS, SR, SRa, SWAP-A
37  2022 Social skills, negative symptoms and real-world functioning in individuals at ultra-high risk of psychosis. EFA, HiSoC, PANSS, UHR
38  2022 Symptom changes in patients with pre-existing psychiatric disorders in the initial phase of the COVID-19 pandemic: Vulnerability of female patients and patients with mood disorders. ---
39  2022 The Chinese version of the family accommodation scale for obsessive-compulsive disorder self-rated: reliability, validity, factor structure, and mediating effect. CGI-S, FA, FAS-IR, FAS-SR, OCD, OCI-R, SDS, Y-BOCS, Zung SDS
40  2022 The effectiveness of repeated intravenous ketamine on subjective and objective psychosocial function in patients with treatment-resistant depression and suicidal ideation. ES, MADRS, SDS, TRD
41  2022 The Feasibility of a Training Program for Peers with Severe Mental Illness to Provide One-to-One Services in Taiwan: A Pilot Study. BPRS-18, CHQ-12, SMI
42  2022 The Impact of Electroconvulsive Therapy on Negative Symptoms in Schizophrenia and Their Association with Clinical Outcomes. BPRS, ECT, IMH, MoCA
43  2022 The outcome of children placed in a welfare center or foster care before the age of 4: Prognostic factors. PIR-GAS
44  2022 Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial. BD, CGI-BP, HAM-A, IR, MADRS, TRBD
45  2022 Validity of the self-rated 36-item World Health Organization Disability Assessment Schedule (WHODAS) 2.0 as a measure of functioning in Swedish psychiatric outpatients. GAF-T, WHODAS
46  2021 A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis. CBT, FAST, FEP, TAU
47  2021 An exploratory evaluation of predictors of duration of untreated psychosis in first-episode psychosis in lower income patients. DUP, PANSS, SAS, SES
48  2021 An integrated youth mental health service in a densely populated metropolitan area in Japan: Clinical case management bridges the gap between mental health and illness services. CCM
49  2021 Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions. PANSS-Positive, QLS
50  2021 Assessment of the Mobile Mental Health Units' effectiveness in Cyclades islands. DALYs, MMHUs, RWE, YLDs
51  2021 Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study. ES-SCZ, ES-SCZ, FEP, PSP
52  2021 BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia. BPRS, CGI, PANSS
53  2021 Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: Analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. GAGE-BD, HAM-D, MADRS, OABD, SD, YMRS
54  2021 Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia. ANZCTR, CGI, hs-CRP, PANSS, PGI-I
55  2021 Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study. DES-II, FEPp, PANSS
56  2021 Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms. CGI-S, PANSS
57  2021 Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. AOM, APpoly, CGI-CB, EMRs, LAIs, PANSS-I
58  2021 Clinical Outcomes of Asynchronous Versus Synchronous Telepsychiatry in Primary Care: Randomized Controlled Trial. ATP, CGI, STP
59  2021 Clozapine Prolongs Cortical Silent Period in Patients with Treatment-Resistant Schizophrenia. CSP, GABA, TRS
60  2021 Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia. FA, HC, IFOF, SZ, WM
61  2021 Comparative outcomes in electroconvulsive therapy (ECT): A naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia. ECT, MoCA, Q-LES-Q-SF, QoL
62  2021 Disorganization in first episode schizophrenia: Treatment response and psychopathological findings from the 2-year follow-up of the "Parma Early Psychosis" program. EIP, FES, PANSS
63  2021 Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms. CUD, DES-II, DUP, FEP, PANSS
64  2021 Effects of Home-visit Occupational Therapy Using a Management Tool for Daily Life Performance on Severe Mental Illness: A Multicenter Randomized Controlled Trial. MTDLP, OT, SFS, SMI
65  2021 Enhancing attention and memory of individuals at clinical high risk for psychosis with mHealth technology. MARS, MCCB, SMART
66  2021 Episode detection based on personalized intensity of care thresholds: a schizophrenia case study. EWMA, SSD
67  2021 Examining disorganization in patients with first episode psychosis: Findings from a 1-year follow-up of the 'Parma early psychosis' program. EIP, FEP, PANSS
68  2021 Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. ES-SCZ, PRS-SCZ
69  2021 First-episode psychosis integrative treatment: Estonian experience. ---
70  2021 Functionality During the First Five Years After the Diagnosis of Schizophrenia. A Cohort Study in a Colombian Population. PSP
71  2021 Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals. CHR, NAPLS-2-RC, SIPS
72  2021 High neutrophil-lymphocyte ratio upon admission is associated with better response in psychotic depression. ECT, NLR, PD
73  2021 Impact of comorbid borderline personality disorder on the outcome of inpatient treatment for anorexia nervosa: a retrospective chart review. AN, BMI, BSI, EDI-2
74  2021 Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach. ---
75  2021 Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes. CAARMS, CHR, rCBF
76  2021 Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder. BD, BPRS, CAE, CGI, HDRS, LAI, SOFAS, TRQ, YMRS
77  2021 Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study. PHQ-9
78  2021 Longitudinal impact of caregiver transition and family caregiving on psychiatric symptoms and psychosocial functioning among persons with schizophrenia in rural China. CMHP, GLM, PANSS, PwSs
79  2021 Longitudinal persistence of negative symptoms in young individuals with first episode schizophrenia: a 24-month multi-modal program follow-up. EIP, FES, PANSS, PNS
80  2021 Medication adherence in bipolar disorder: Exploring the role of predominant polarity. ANCOVA, BPAD, DPP, IPP, MMAS, MPP, PP, WHOQOL-Bref
81  2021 Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications. 22q11.2DS, NLR, SOPS
82  2021 Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate. aLAI
83  2021 Personal health budget in patients with first episode psychosis: A new rehabilitation model based on a community care system in Italy. ANOVA, BPRS, FEP, HoNOS, PHBs
84  2021 Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection. QLS, SNPs
85  2021 Prevalence and profile of depressive mixed state in patients with autism spectrum disorder. ASD, DMX, MD, MDE, MF, QIDS-SR-J
86  2021 Prevalence of Circadian Rhythm Sleep-Wake Disorder in Outpatients with Schizophrenia and Its Association with Psychopathological Characteristics and Psychosocial Functioning. BPRS, CGI-S, CRSWD, ISI, MEQ
87  2021 Psychosocial functioning in adolescents with non-suicidal self-injury: the roles of childhood maltreatment, borderline personality disorder and depression. BPD, CM, NSSI
88  2021 Reduction of phonetic mismatch negativity may depict illness course and predict functional outcomes in schizophrenia. EEG, HC, MMN, PANSS, SZ
89  2021 Resilience in severe mental disorders: correlations to clinical measures and quality of life in hospitalized patients with major depression, bipolar disorder, and schizophrenia. BPRS, CGI, CIRS, HAM-D, YMRS
90  2021 Sex Differences in Recovery-Related Outcomes and Needs for Psychiatric Rehabilitation in People With Schizophrenia Spectrum Disorder. SSDs, STORI
91  2021 Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS). FEP, TEPS
92  2021 Six months functional response to early psychosis intervention program best predicts outcome after three years. ---
93  2021 Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia. 22q11DS, PAS, PS
94  2021 Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial. ---
95  2021 The association between reflective function and global functionality in patients with borderline personality disorder. BPD, DSQ-40, RFQ, SCID-II
96  2021 The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds. FAST, FEP, LRA
97  2021 The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participants: A machine learning and modelling approach. BAC, CHR-P, HCs
98  2021 The Relationship between PID-5 Personality Traits and Mental States. A Study on a Group of Young Adults at Risk of Psychotic Onset. PID-5, SOFAS
99  2021 The social support, mental health, psychiatric symptoms, and functioning of persons with schizophrenia participating in peer co-delivered vocational rehabilitation: a pilot study in Taiwan. BPRS, C-SFS, C-SFS, CHQ-12, SSS, VPS
100  2021 The Turkish Validity and Reliability Study of the Observable Social Cognition -A Rating Scale for Patients with Schizophrenia. DEZIKO, FEDT/FEIT, OSCARS, PANSS